Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vihang Nakhate

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Neuro-Oncology Practice|June 9, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastomaJohn Y Rhee, Carissa Mastrangelo, Paul J Miller, et al.
Cancer Discovery|July 18, 2015
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to MelanomaAndrew S McNeal, Kevin Liu, Vihang Nakhate, et al.
Journal of Neuro-Oncology|May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology Advances|February 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitorsVihang Nakhate, Catharina Westergaard, Zhou Lan, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neuro-Oncology Practice|June 9, 2025
A pilot study to quantify and describe personal social networks in patients with glioblastomaJohn Y Rhee, Carissa Mastrangelo, Paul J Miller, et al.
Cancer Discovery|July 18, 2015
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to MelanomaAndrew S McNeal, Kevin Liu, Vihang Nakhate, et al.
Journal of Neuro-Oncology|May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology Advances|February 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitorsVihang Nakhate, Catharina Westergaard, Zhou Lan, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Pageof 2